176 related articles for article (PubMed ID: 26399565)
1. Binding domains of Bacillus anthracis phage endolysins recognize cell culture age-related features on the bacterial surface.
Paskaleva EE; Mundra RV; Mehta KK; Pangule RC; Wu X; Glatfelter WS; Chen Z; Dordick JS; Kane RS
Biotechnol Prog; 2015; 31(6):1487-93. PubMed ID: 26399565
[TBL] [Abstract][Full Text] [Related]
2. The 1.6 A crystal structure of the catalytic domain of PlyB, a bacteriophage lysin active against Bacillus anthracis.
Porter CJ; Schuch R; Pelzek AJ; Buckle AM; McGowan S; Wilce MC; Rossjohn J; Russell R; Nelson D; Fischetti VA; Whisstock JC
J Mol Biol; 2007 Feb; 366(2):540-50. PubMed ID: 17182056
[TBL] [Abstract][Full Text] [Related]
3. The secondary cell wall polysaccharide of Bacillus anthracis provides the specific binding ligand for the C-terminal cell wall-binding domain of two phage endolysins, PlyL and PlyG.
Ganguly J; Low LY; Kamal N; Saile E; Forsberg LS; Gutierrez-Sanchez G; Hoffmaster AR; Liddington R; Quinn CP; Carlson RW; Kannenberg EL
Glycobiology; 2013 Jul; 23(7):820-32. PubMed ID: 23493680
[TBL] [Abstract][Full Text] [Related]
4. Role of net charge on catalytic domain and influence of cell wall binding domain on bactericidal activity, specificity, and host range of phage lysins.
Low LY; Yang C; Perego M; Osterman A; Liddington R
J Biol Chem; 2011 Sep; 286(39):34391-403. PubMed ID: 21816821
[TBL] [Abstract][Full Text] [Related]
5. Phage endolysins with broad antimicrobial activity against Enterococcus faecalis clinical strains.
Proença D; Fernandes S; Leandro C; Silva FA; Santos S; Lopes F; Mato R; Cavaco-Silva P; Pimentel M; São-José C
Microb Drug Resist; 2012 Jun; 18(3):322-32. PubMed ID: 22480295
[TBL] [Abstract][Full Text] [Related]
6. Characterization of an endolysin, LysBPS13, from a Bacillus cereus bacteriophage.
Park J; Yun J; Lim JA; Kang DH; Ryu S
FEMS Microbiol Lett; 2012 Jul; 332(1):76-83. PubMed ID: 22524239
[TBL] [Abstract][Full Text] [Related]
7. Characterisation of the antibacterial properties of the recombinant phage endolysins AP50-31 and LysB4 as potent bactericidal agents against Bacillus anthracis.
Park S; Jun SY; Kim CH; Jung GM; Son JS; Jeong ST; Yoon SJ; Lee SY; Kang SH
Sci Rep; 2018 Jan; 8(1):18. PubMed ID: 29311588
[TBL] [Abstract][Full Text] [Related]
8. Discovery and Biochemical Characterization of PlyP56, PlyN74, and PlyTB40-
Etobayeva I; Linden SB; Alem F; Harb L; Rizkalla L; Mosier PD; Johnson AA; Temple L; Hakami RM; Nelson DC
Viruses; 2018 May; 10(5):. PubMed ID: 29883383
[TBL] [Abstract][Full Text] [Related]
9. Taking aim on bacterial pathogens: from phage therapy to enzybiotics.
Hermoso JA; García JL; García P
Curr Opin Microbiol; 2007 Oct; 10(5):461-72. PubMed ID: 17904412
[TBL] [Abstract][Full Text] [Related]
10. Muralytic activity and modular structure of the endolysins of Pseudomonas aeruginosa bacteriophages phiKZ and EL.
Briers Y; Volckaert G; Cornelissen A; Lagaert S; Michiels CW; Hertveldt K; Lavigne R
Mol Microbiol; 2007 Sep; 65(5):1334-44. PubMed ID: 17697255
[TBL] [Abstract][Full Text] [Related]
11. Catalytic diversity and cell wall binding repeats in the phage-encoded endolysins.
Broendum SS; Buckle AM; McGowan S
Mol Microbiol; 2018 Dec; 110(6):879-896. PubMed ID: 30230642
[TBL] [Abstract][Full Text] [Related]
12. PlyPH, a bacteriolytic enzyme with a broad pH range of activity and lytic action against Bacillus anthracis.
Yoong P; Schuch R; Nelson D; Fischetti VA
J Bacteriol; 2006 Apr; 188(7):2711-4. PubMed ID: 16547060
[TBL] [Abstract][Full Text] [Related]
13. A bacteriolytic agent that detects and kills Bacillus anthracis.
Schuch R; Nelson D; Fischetti VA
Nature; 2002 Aug; 418(6900):884-9. PubMed ID: 12192412
[TBL] [Abstract][Full Text] [Related]
14. The antibacterial activity of E. coli bacteriophage lysin lysep3 is enhanced by fusing the Bacillus amyloliquefaciens bacteriophage endolysin binding domain D8 to the C-terminal region.
Wang S; Gu J; Lv M; Guo Z; Yan G; Yu L; Du C; Feng X; Han W; Sun C; Lei L
J Microbiol; 2017 May; 55(5):403-408. PubMed ID: 28124780
[TBL] [Abstract][Full Text] [Related]
15. Novel chimerical endolysins with broad antimicrobial activity against methicillin-resistant Staphylococcus aureus.
Fernandes S; Proença D; Cantante C; Silva FA; Leandro C; Lourenço S; Milheiriço C; de Lencastre H; Cavaco-Silva P; Pimentel M; São-José C
Microb Drug Resist; 2012 Jun; 18(3):333-43. PubMed ID: 22432707
[TBL] [Abstract][Full Text] [Related]
16. Structure and lytic activity of a Bacillus anthracis prophage endolysin.
Low LY; Yang C; Perego M; Osterman A; Liddington RC
J Biol Chem; 2005 Oct; 280(42):35433-9. PubMed ID: 16103125
[TBL] [Abstract][Full Text] [Related]
17. Characterization of AmiBA2446, a novel bacteriolytic enzyme active against Bacillus species.
Mehta KK; Paskaleva EE; Azizi-Ghannad S; Ley DJ; Page MA; Dordick JS; Kane RS
Appl Environ Microbiol; 2013 Oct; 79(19):5899-906. PubMed ID: 23872558
[TBL] [Abstract][Full Text] [Related]
18. Structural insights into the binding and catalytic mechanisms of the Listeria monocytogenes bacteriophage glycosyl hydrolase PlyP40.
Romero P; Bartual SG; Schmelcher M; Glück C; Hermoso JA; Loessner MJ
Mol Microbiol; 2018 Apr; 108(2):128-142. PubMed ID: 29405497
[TBL] [Abstract][Full Text] [Related]
19. Lysins as a powerful alternative to combat Bacillus anthracis.
Nakonieczna A; Abramowicz K; Kwiatek M; Kowalczyk E
Appl Microbiol Biotechnol; 2024 Jun; 108(1):366. PubMed ID: 38850320
[TBL] [Abstract][Full Text] [Related]
20. Domain shuffling and module engineering of Listeria phage endolysins for enhanced lytic activity and binding affinity.
Schmelcher M; Tchang VS; Loessner MJ
Microb Biotechnol; 2011 Sep; 4(5):651-62. PubMed ID: 21535426
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
